Shana Traina's Experience:
-
Director at Janssen Pharmaceuticals
October 2012 - Present | Raritan• Develop and execute market access strategies for pharmaceutical products in development – focusing on oncology, cardiovascular, metabolism • Build foundations for successful life-cycle management programs by identifying the value drivers of key indications to optimize the commercial trajectory of products and continue to elucidate the value of products from the patient perspective in various disease states • Position company to achieve success with respect to forming strong cases for pricing and reimbursement negotiations by translating insights from the literature, non-interventional studies, and clinical trials into value statements and training global business partners to optimize use of the data • Ensure forward thinking and informed preparation for launching future products by providing strategic vision of the healthcare landscape • Provide leadership in the development of new PRO tools to assess the patient impact of diseases and treatments • Expand scientific understanding of the patient impact of disease through publications that lay the groundwork for scientific value messages • Develop FDA briefing books for meetings with FDA to discuss PRO tool development to gain label claims • Grow solid partnerships with external disease area experts and cultivate meaningful relationships with internal business partners to build trust and forge collaboration • Accountable for team member engagement and proactive milestone recognition to promote greater sense of progress toward business solutions • Encourage team members to take on leadership roles to build confidence and experience
-
Health Economist at Amgen
October 2005 - Present | Thousand OaksHealth Economics and Outcomes Research, Patient-Reported Outcomes Expert. • Developed economic- and cost-effectiveness models and global value dossiers to support market access strategies for products in development – primarily in immunology and oncology • Established PRO strategies and implemented them in study protocols, statistical analysis plans, and clinical study reports to support regulatory filings for new compounds • Enhanced product value messaging through publications highlighting product benefits from the patient perspective • Built, trained, and managed teams to implement health-related quality of life surveys in observational studies and randomized clinical trials.
-
Researcher at RAND
1997 - Present | Santa MonicaRand Health assocaiate researcher. • Co-moderated 20 focus groups of children and parents on general health topics • Procured over 2000 journal articles, developed database tracking mechanism for clinical ratings of each article, and prepared AHRQ publications summarizing results from meta-analyses of the article findings
-
Associate Director at Johnson & Johnson
July 2007 - October 2012 -
Associate Director at Johnson & Johnson Pharmaceutical Services
July 2007 - October 2012 -
Graduate Student Researcher at VA Hospital
January 2002 - December 2005 | Rheumatology DivisionModerated focus groups of patients with scleroderma to learn about their experience with the disease. Coordinated grant writing, project planning, implementation, analysis, interpretation of results, and manuscript writing.
This BrandYourself profile is automatically optimized to show up high in Google 